Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? Article

Calonge, Ned, Klein, Roger D, Berg, Jonathan S et al. (2014). Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? . GENETICS IN MEDICINE, 16(4), 338-346. 10.1038/gim.2013.141

Open Access

cited authors

  • Calonge, Ned; Klein, Roger D; Berg, Jonathan S; Campos-Outcalt, Doug; Djulbegovic, Benjamin; Ganiats, Theodore; Janssens, A Cetile JW; Offit, Kenneth; Pauker, Stephen G; Piper, Margaret; Richards, Carolyn Sue; Strickland, Ora L; Tunis, Sean; Williams, Marc S; Zallen, Doris

sustainable development goals

authors

publication date

  • April 1, 2014

published in

keywords

  • ANTIGEN
  • BIOPSY
  • GENE 3 PCA3
  • Genetics & Heredity
  • Life Sciences & Biomedicine
  • MEN
  • MOLECULAR URINE ASSAY
  • PCA3
  • PERFORMANCE
  • RISK
  • SCORE
  • Science & Technology
  • TUMOR VOLUME
  • VALIDATION
  • diagnosis
  • genetic testing
  • management
  • prostate cancer
  • recommendation

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 338

end page

  • 346

volume

  • 16

issue

  • 4